memantine has been researched along with Arthritis, Degenerative in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine is a clinically licensed drug used for the treatment of moderate and severe Alzheimer's disease." | 1.46 | Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs). ( Li, W; Wang, L; Wu, Z; Yu, Y; Zhao, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, J | 1 |
| Yu, Y | 1 |
| Wu, Z | 1 |
| Wang, L | 1 |
| Li, W | 1 |
1 other study available for memantine and Arthritis, Degenerative
| Article | Year |
|---|---|
Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Topics: Cartilage, Articular; Cell Line, Tumor; Chondrocytes; Chondrosarcoma; Collagen Type II; Extracellula | 2017 |